Targeted segmental volume reduction with vapor ablation in emphysema results in reduced RV and clinically meaningful improvement (CMI) in FEV1

Andre Costa-Pozza (Dublin, Ireland), Jim J. Egan, Daniela Gompelmann, Pallav L. Shah, Christian Grah, Arschang Valipour, Joachim H. Ficker, Manfred Wagner, Christian Witt, Uta Liebers, Peter Hopkins, Wolfgang Gesierich, Martin Phillips, Franz Stanzel, William H. McNulty, Christoph Petermann, Greg Snell, Ralf Eberhardt, Felix J.F. Herth, Andre Costa-Pozza

Source: International Congress 2016 – Endoscopic lung volume reduction II
Session: Endoscopic lung volume reduction II
Session type: Poster Discussion
Number: 1850

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Andre Costa-Pozza (Dublin, Ireland), Jim J. Egan, Daniela Gompelmann, Pallav L. Shah, Christian Grah, Arschang Valipour, Joachim H. Ficker, Manfred Wagner, Christian Witt, Uta Liebers, Peter Hopkins, Wolfgang Gesierich, Martin Phillips, Franz Stanzel, William H. McNulty, Christoph Petermann, Greg Snell, Ralf Eberhardt, Felix J.F. Herth, Andre Costa-Pozza. Targeted segmental volume reduction with vapor ablation in emphysema results in reduced RV and clinically meaningful improvement (CMI) in FEV1. Eur Respir J 2016; 48: Suppl. 60, 1850

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Volume changes after segmental vapor ablation and associated improvements in FEV1
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016


Targeted vapor ablation as a new method for endoscopic lung volume reduction at segmental level
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016


Segmental lung volume reduction (LVR) with vapor better targets disease heterogeneity as compared to lobar LVR
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016


Dynamic hyperinflation after bronchial lung volume reduction: An expected effect or perhaps a preoperative test for selection?
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013


Endoscopic lung volume reduction (ELVR) in COPD: Improvements in gas transfer capacity correlate with improvements in ventilation and perfusion (VQ) matching
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015


Echocardiogram parameters in patients with COPD in the year after endoscopic lung volume reduction (ELVR)
Source: International Congress 2015 – Bronchoscopic treatment of emphysema and asthma: what is new?
Year: 2015


Lung volume reduction coil treatment restores lung compliance in patients with homogeneous emphysema
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013

Bronchoscopic lung volume reduction with endobronchial valves improves exercise capacity but not oxygen uptake kinetics in a group of patients with severe emphysema
Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases
Year: 2013

Patient selection and efficacy of valve bronchoscopic lung volume reduction (BLVR) in emphysema
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016

Role of quantitative perfusion scintigraphy evaluation in determination of the efficiency of the procedure before lung volume reduction coil (LVRC) treatment for severe emphysema
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016

Endoscopic lung volume reduction in low FEV1 patients
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016


Lung volume reduction coil (LVRC) treatment is safe and effective in heterogeneous and homogeneous emphysema
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013


Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema
Source: Eur Respir J 2012; 39: 1326-1333
Year: 2012



Lung volume reduction for severe emphysema: do we need a scalpel or a scope?
Source: Eur Respir Rev 2010 19: 242-247
Year: 2010



Endoscopic lung volume reduction with nitinol coils in very severe emphysema: Mid-term effectiveness vs. disease related continuous loss of lung function
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015

Flow-volume parameters in COPD related to extended measurements of lung volume, diffusion and resistance
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013


Unilateral treatment with lung volume reduction coils in patients with severe emphysema
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013

Ability for dynamic hyperinflation increases after bronchoscopic lung volume reduction in patients with severe emphysema.
Source: International Congress 2017 – Endoscopic lung volume reduction (EVLR) and targeted lung denervation (TLD)
Year: 2017

CT assessment of lobar heterogenity and fissure integrity in pulmonary emphysema for bronchoscopic lung volume reduction with valve
Source: International Congress 2015 – A morphological view of chest pathology
Year: 2015


Measurement of lung function deterioration in COPD by V/P SPECT
Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception
Year: 2016